[Plasma levels of halofantrine during two therapeutic sessions at a 7 day interval].
Keundjian
A
A
Touze
J E
JE
Bernard
J
J
Bertherat
E
E
Soares
J L
JL
D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016778:Malaria, Falciparum / Q000097:blood* / Q000188:drug therapy; D010616:Phenanthrenes / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use
D000962:Antimalarials; D010616:Phenanthrenes; C044961:1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol; C023768:halofantrine
Concentrations plasmatiques de l'halofantrine lors de 2 cures thérapeutiques à 7 jours d'intervalle.